GSK Gsk Plc

TIDMGSK

RNS Number : 3373G

GlaxoSmithKline PLC

23 July 2021

GlaxoSmithKline plc

Board Committee Changes

GlaxoSmithKline plc today announces the following change to its Board Committee membership effective 23 July 2021.

Dr Anne Beal has been appointed a member of the Audit & Risk Committee. This appointment is in addition to her membership of the Corporate Responsibility Committee.

V A Whyte

Company Secretary

23 July 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOADKNBBNBKDFOB

(END) Dow Jones Newswires

July 23, 2021 09:32 ET (13:32 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Jan 2025 to Feb 2025

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Feb 2025